Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (181-190 of 273) with videos related to

Pageof 28
Sort By:
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
Circulation. Cardiovascular Interventions|February 27, 2023
Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary StenosisDavid Hong, Doosup Shin, Seung Hun Lee, et al.
Revista Espanola De Cardiologia (English Ed.)|March 5, 2025
Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysisDavid Hong, Minseok Hong, Onyou Kim, et al.
Journal of the American Heart Association|January 25, 2023
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular DeathDavid Hong, Seung Hun Lee, Doosup Shin, et al.
Oncotargets and Therapy|May 17, 2021
A Phase I Trial of the MET/<i>ALK/ROS1</i> Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid MalignanciesSarina A Piha-Paul, Ecaterina E Dumbrava, Binoj C Nair, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 19, 2006
Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorderSoyoung Irene Lee, Sungdo David Hong, Sang-Yeup Kim, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Kidney International Reports|January 16, 2023
Prognostic Impact of Coronary Flow Reserve in Patients With CKDSugeon Park, Seung Hun Lee, Doosup Shin, et al.
Journal of Medicinal Chemistry|April 23, 2026
Second-Generation Anti-Tubercular Squaramides Targeting Complex V of the Respiratory Chain of <i>Mycobacterium tuberculosis</i> Displaying Enhanced Metabolic StabilityNada Mosallam, Paul M O'Neill, Monika LisauskaitÄ—, et al.
The Oncologist|December 13, 2025
Phase I Study of Bevacizumab and Temsirolimus Combination Therapy in Advanced Malignancies: Safety, Efficacy, and Ovarian Cancer ExpansionSarina A Piha-Paul, Chieh Tseng, Emily Thompson, et al.
Pageof 28

Showing results (181-190 of 273) with videos related to

Sort By:
Pageof 28
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
Circulation. Cardiovascular Interventions|February 27, 2023
Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary StenosisDavid Hong, Doosup Shin, Seung Hun Lee, et al.
Revista Espanola De Cardiologia (English Ed.)|March 5, 2025
Efficacy and safety of SGLT2 inhibitors in patients with heart failure according to kidney function: a systematic review and meta-analysisDavid Hong, Minseok Hong, Onyou Kim, et al.
Journal of the American Heart Association|January 25, 2023
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular DeathDavid Hong, Seung Hun Lee, Doosup Shin, et al.
Oncotargets and Therapy|May 17, 2021
A Phase I Trial of the MET/<i>ALK/ROS1</i> Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid MalignanciesSarina A Piha-Paul, Ecaterina E Dumbrava, Binoj C Nair, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 19, 2006
Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorderSoyoung Irene Lee, Sungdo David Hong, Sang-Yeup Kim, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Kidney International Reports|January 16, 2023
Prognostic Impact of Coronary Flow Reserve in Patients With CKDSugeon Park, Seung Hun Lee, Doosup Shin, et al.
Journal of Medicinal Chemistry|April 23, 2026
Second-Generation Anti-Tubercular Squaramides Targeting Complex V of the Respiratory Chain of <i>Mycobacterium tuberculosis</i> Displaying Enhanced Metabolic StabilityNada Mosallam, Paul M O'Neill, Monika LisauskaitÄ—, et al.
The Oncologist|December 13, 2025
Phase I Study of Bevacizumab and Temsirolimus Combination Therapy in Advanced Malignancies: Safety, Efficacy, and Ovarian Cancer ExpansionSarina A Piha-Paul, Chieh Tseng, Emily Thompson, et al.
Pageof 28